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Abstract	
Confinement during the COVID-19 pandemic is expected to have a serious and 
complex impact on the mental health of patients with an eating disorder (ED) and of patients with 
obesity. The present manuscript has the following aims: 1) to analyze the psychometric properties 
of the COVID Isolation Eating Scale (CIES), 2) to explore changes that occurred due to 
confinement in eating symptomatology; and 3) to explore the general acceptation of the use of 
telemedicine during confinement. The sample comprised 121 participants (87 ED patients and 34 
patients with obesity) recruited from six 
different centers.Confirmatory Factor Analyses (CFA) tested the rational-theoretical 
structure of the CIES. Adequate goodness-of-fit was obtained for the confirmatory factor analysis, 
and Cronbach alpha values ranged from good to excellent. Regarding the effects of 
confinement, positive and negative impacts of the confinement depends of the eating disorder 
subtype. Patients with anorexia nervosa (AN) and with obesity endorsed a positive response to 
treatment during confinement, no significant changes were found in bulimia nervosa 
(BN) patients, whereas Other Specified Feeding or Eating Disorder (OSFED) patientsendorsed an 
increase in eating symptomatology and in psychopathology. Furthermore, AN patients expressed 
the greatest dissatisfaction and accommodation difficulty with remote therapy when compared 
with the previously provided face-to-face therapy. The present study provides empirical evidence 
on the psychometric robustness of the CIES tool and shows that a negative confinement impact 
was associated with ED subtype, whereas OSFED patients showed the highest impairment in 
eating symptomatology and in psychopathology. 	
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Background	
In just a few months, COVID-19 has become a global pandemic that has brought numerous 
challenges to health professionals and their patients. To stop the speed of the spread of the virus, 
most governments have chosen to place their populations under confinement, which has implied 
radical changes in social interactions and the way work was conducted. The final repercussions of 
confinement are still under investigation, though it is expected to have a significant impact on 
mental health for many.	
Considering other health and humanitarian crises, such as the Ebola and H1N1 
influenza epidemics, depression (Hewlett & Hewlett, 2005; Kinsman, 2012), isolation, fear of 
being infected, posttraumatic stress (Li et al., 2018; Raven et al., 2018) and health 
anxiety (McDonnell et al., 2012) have been some of the negative effects on mental health reported 
by the general population, health workers and survivors of past epidemics. Confinement has been 
found to increase the incidence of negative states such as irritability, insomnia, anger, depression 
symptoms, among others (Brooks et al., 2020).	
In response to the COVID-19 pandemic, several studies have already been carried out to explore 
the psychological effects of the pandemic and confinement. In the general population, anxiety, 
depression, stress, worry about being infected, worry about family members being infected, worry 
about financial stress stability, post-traumatic stress (Cao et al., 2020; Mowbray, 2020; Wang, 
Pan, et al., 2020; Wang, Di et al., 2020), but also mental health deterioration (Pierce et al., 2020) 
and nutritional and activity patterns changes (Papandreou et al., 2020), have been reported. 
Healthcare workers have emerged as a specific population in danger of suffering from 
psychological distress, depression, anxiety and insomnia (Inchausti et al., 2020; Kang et al., 2020; 
Lai et al., 2020; Rossi et al., 2020) and populations with a prior mental health condition may 
experience an increase in their symptomatology related to changes in the delivery of their usual 
treatment (Dalle Grave, 2020; De Girolamo et al., 2020; Fernández-Aranda et al., 2020; Inchausti 
et al., 2020).	
It is important to consider that stay-at-home and social-distancing mandates have increased the 
frequency of several risk behaviours. The time available for engaging in potentially addictive 
behaviours, such as online gambling, gaming, and pornography (Håkansson et al., 2020; Király et 
al., 2020; Mestre-Bach et al., 2020) has increased and these behaviours, along with the use of 
alcohol or other substances, may be used as coping strategies to avoid negative emotional 
states/span>(Håkansson et al., 2020; King et al., 2020; Király et al., 2020; Sun et al., 
2020). Although these behaviors do not constitute a risk for all individuals, the current situation 
may increase the risk for onset, maintenance, and relapse, especially for the most vulnerable 
individuals (Columb et al., 2020; Marsden et al., 2020), such as patients with an eating disorders 
and patients with obesity (Baenas et al.,2020; Graell et al., 2020; Cornejo-Pareja et al., 2020), as 
well as patients with less favorable family environments (Vintro et al., 2018).	
It has been hypothesized that the COVID-19 pandemic may exacerbate the risk factors for 
overeating and unhealthy weight gain, especially in vulnerable populations such as children and 
individuals with an eating disorder (ED) and obesity (Rundle et al., 2020,Graell et al., 2020). ED 
patients have already reported increased worries about the risk of being infected with COVID-
19, disruptions in their work and treatment, the worsening of their ED symptoms, as well as 
heightened anxiety and stress (Fernández-Aranda et al., 2020a). ED patients and individuals with 
obesity constitute vulnerable populations whorequire targeted approaches (Cornejo-Pareja et al., 
2020). As an immediate emergency measure to address this situation, different telemedicine tools 
during the pandemic have been described within this population (Cooper et al., 2020; Smith et al., 
2020), however there is a lack of studies looking at their effectiveness and acceptability by users.  	
New psychometric instruments have been developed to measure different features related to the 
Covid-19 pandemic, such as the contextual situation lived during the confinement, the changes 
occurring in the individuals’ life and the impact on their health state. Some of these new scales 
are: the Fear of COVID-19 Scale (FCV-19S; (Ahorsu et al., 2020; Sakib et al., 2020; Soraci et al., 
2020), the COVID-19 Anxiety Scale (CAS; (Chandu et al., 2020), the COVID-19-PTSD (Forte et 
al., 2020), the CoViD-19 Peritraumatic Distress Index (CPDI; (Costantini & Mazzotti, 2020), the 
Coronavirus Impact Scale (CIS; Kaufman  et al., 2020) and the COVID Stress 
Scales (CSS; (Taylor et al., 2020), including COVID danger and contamination fears, COVID 
fears about economic consequences, COVID xenophobia, COVID compulsive checking and 
reassurance seeking, and COVID traumatic stress symptoms. However, to the best of our 
knowledge, no tool has yet been developed and validated to 
assess eating disorder symptomatology and treatment-related aspects in patients with an ED and 
obesity.	
Goals	
The aims of this exploratory study were threefold: 1) to analyze the psychometric properties of the 
COVID Isolation Eating Scale (CIES), a newly created scale for measuring the impact of 
confinement; 2) to explore changes that occurred due to confinement (eating symptomatology and 
weight, attitudes and dysfunctional emotions, worries and concerns, anxiety and depressive 
symptomatology and addictive behaviours); 3) to explore the potential difficulties for participants 
in using telemedicine during confinement when usual health care was interrupted. Based on 
previous literature (Baenas et al., 2020; Fernández-Aranda et al., 2020; Temorshuizen et al., 
2020), we hypothetizedspan	 style="font-family:'Times	 New	 Roman'">	 that	 eating	 disorder	
subtype	and	obesity	would	achieve	a	moderator/interaction	role	 in	the	changes	occurred	
during	 the	 confinement:	behavioural and emotional reactions, eating patterns-weight, anxiety 




The data collection of this study was conducted between June and July 2020. Our study sample 
comprised 121 participants (87 ED patients and 34 patients with obesity), recruited 
from six different child-adolescent and adult units from 
the Barcelona (Spain) region. These centers are representative of the public and private sectors of 
ED treatment services in Barcelona. Participants were involved in ED treatment before the 
outbreak of COVID-19 and were asked by therapists from each center if they were 
willing to voluntarily complete the study questionnaire. The ED sample was diagnosed according 
to DSM-5 criteria (American Psychiatric Association, 2013) by means of a semi-structured 
interview. Obese participants were bariatric surgery candidates who were recruited at 
the Endocrinological Unit at the Clinic Hospital of Barcelona.	
The sex distribution was 104 women (86.0%)  and 17 men (14.0%). The age range 
was broad (mean=33.7,	 SD=15.8), ranging from 13 to 77. The distribution of the 
ED diagnoses was as follows: 55 cases met criteria for anorexia nervosa (AN), 18 for bulimia 
nervosa (BN), 14 were diagnosed with an Other Specified Feeding or Eating Disorder 
(OSFED). Table S1 (supplementary material) contains the distribution of sex and age within the 
groups defined by diagnosis. No statistical differences by gender were obtained (c2=4.06, 
df=3, p=.256). However, chronological age was not equally distributed between groups (F=30.08, 
df=3/117, p<.001): obese patients were  the oldest  (mean=48.8, SD=12.9), followed by OSFED 
(mean=36.9, SD=16.4), BN (mean=31.5, SD=10.1) and AN (mean=24.2, SD=10.7) patients.	
 	
Assessment	
The COVID Isolation Eating Scale (CIES) is a self-report questionnaire that assess the impact of 
confinement in patients with an eating disorder and/or obesity. This measure has been designed to 
be answered both with paper and pencil or online. The scale was generated by experts in the ED 
area through a theoretical-rationale procedure based on the next steps: a) identification of the 
domains (constructs/areas) endeavouring to measure; b) deciding the number of 
factors/dimensions and their position into a meaningful order and format into the questionnaire; 
and c) generating the items, as well as their distribution within each factor/dimension. After the 
development of the item pool, independent expert judges assessed whether the items adequately 
represented the domains of interest. The final CIES, besides exploring patient sociodemographic 
information, the scale was divided into four sections: I) Circumstances during confinement (eight 
items characteristing the circumstances of confinement). II) Effects of	 confinement	 on	
eating	disorder symptoms (thirteen items relating to the eating symptomatology of anorexia 
nervosa, bulimia nervosa, binge eating disorder and other specified feeding or eating disorder, 
according to the DSM-5 and comorbid physical and psychiatric disorders. III) Behavioral and 
psychopathological impact of confinement (thirty-four items covering the effects of confinement 
on eating patterns, attitudes and habits, anxiety-depression symptomatology, emotion 
dysregulation, and other symptomatology associated with substance use disorders and non-
substance related addictive behaviours. IV) Evaluation of remote interventions (thirteen items 
assessing the feasibility, acceptance and satisfaction). The three last scales are answered on a five-
point Likert scale. Sections II and III consider two moments of time: before confinement 
and now, the present (for the English version of CIES Scale and translation 
in 17 languages see Supplementary information online).	
 	
Additional information	
Socio-demographic/clinical information, including age, affiliation to the patient with an ED, and 
marital status, but also variables related to COVID and duration and type of the confinement was 
obtained along with the CIES questionnaire.	
 	
Procedure	
The present study was approved by the Clinical Research Ethics Committee of Bellvitge 
University Hospital (PR239/20). Written and signed informed consent was obtained from all 
participants before taking part in the study. 	
 	
Statistical Analysis	
Statistical analyses were carried out with Stata16 for Windows (Stata Press, 2019). Based on 
the theoretical-rational method used to develop the CIES,confirmatory factor analyses (CFA) was 
used to verify the factor structure of the questionnaire. CFA was implemented through structural 
equation modeling, defining the maximimun likelihood, and considering adequate goodness of fit 
for Root Mean squared Error of Approximation RMSEA<0.08, Comparative Fit Index CFI>0.90, 
Tucker-Lewis Index TLI>0.90 and Standardized Root Mean Squared Residuals 
SRMR<0.10 (Barrett, 2007).	
An initial CFA assumed the existence of five latent theoretical factors: Factor 1 was defined by 10 
items measuring eating related symptoms (such as concerns about weight, attempts to reduce 
eating quantities and meals, presence of binging/purging, use of laxatives/diuretics, and exercise 
or other activities to control weight); Factor 2 was defined by 10 items measuring the effects of 
confinement on the eating related style (such as being unable to stop eating during the day, or 
between meals or certain foods); Factor 3 was defined by 11 items assessing anxiety and 
depressive symptoms (sleep problems, upsetting thoughts, loneliness, limited social contact, 
health concerns related to COVID-19, or sexual problems); Factor 4  was defined by 5 items 
related to emotion regulation (emotional control/awareness, anger/shame, aggressive bhaviors and 
irritability); and Factor 5 was defined by 10 items to evaluate telemedicine (adequacy, motivation, 
satisfaction and usefulness). Factors F1, F2, F3 and F4 were also developed to 
allow for assessment prior and following COVID-19 confinement. However, it was not possible 
to test the initial single CFA for the five-dimension model, because the sample size was too 
small to verify this complex structure (fit was not obtained). According to the sample size, 
separate models were tested for each dimension, programming within the same model the 
measures for the pre- and the post-confinement to account for the expected correlations between 
both periods. Figure S1 (supplementary material) contains the path diagrams for the individual 
constructs tested in this manuscript.	
The pre-post changes in the quantitative variables of the study were based on paired-sample t-
tests for interval scaled variables, and on the McNemar test for categorical measures. The 
comparison between groups defined by the diagnosis (AN, BN, OSFED and obese) was based on 
analysis of variance analyses (ANOVAs), with post-hoc pairwise comparisons 
estimated via Bonferroni’s procedure. For all these analyses, significant tests were complemented 
with the estimation of the effect size through Cohen’s-d coefficient, considering null effet for 
|d|<0.20, low-poor for |d|>0.20, mild-medium for |d|>0.50 and large-high for |d|>0.80) (Cohen, 
1988; Kelley & Preacher, 2012).	
Results	
Characteristics of the participants during the COVID-19 confinement	
During the lockdown period, 30 (24.8%) participants lived alone, and 32 (26.4%) lived with 1 or 
2 people at home, 29 (24.0%) lived with 3 people, and the remaining 30 participants (24.8%) 
lived with more than 3 people. Most participants were not infected by COVID-19 (n=115, 
95.0%) and most had no infections among people close to them  (n=94, 77.7%). Most 
participants did not  report a caring role during the confinement (n=84, 69.4%). 58% (70 
participants) continued to work and 69% (83 participants) had no financial loss. No statistical 
differences between groups were observed for these contextual variables during  lockdown (Table 
S1, supplementary material, contains the frequency distribution within the groups).	
 	
Psychometric properties of the CIES	
The factorial analyses confirmed the rational-theoretical structure for the CIES. All the 
items obtained significant factor loadings for their specific factor (Table S2, supplementary 
material, includes the standardized coefficients, standard errors, p-values and 95% confidence 
intervals). The upper block of Table 1 includes the fit indices of the CFAs and the internal 
consistency coefficients of the factors/scales: adequate goodness-of-fit was obtained , and 
Cronbach alpha coefficients ranged from good (a=0.81, for the factor F1-impacts at pre-
confinement)  to excellent (a=0.92, for F2-changes in eating at pre-confinement). The bottom 
block of Table 1 contains the correlation matrix for the factor scores. Relevant positive correlations 
(with |R| coefficients above 0.24) were obtained for the factors F1, F2, F3 and F4, for both at pre-
confinement and after the confinement, with the only exception of F1-post which did not correlate 
with F3-pre and F4-pre. However, no relevant correlations emerged between F5 (evaluation of 
telemedicine) and the other factors.	
--- Insert Table 1 ---	
Impact of the COVID-19 on eating related behaviors 	
Table 2 contains the main changes in weight, BMI, CIES  factors F1 to F4, the consumption of 
substances and the presence of other addictive behaviours. Separate analyses were performed 
according to the diagnostic subtype, since it was hypothesized that the diagnosis could influence 
pre-post differences. Within AN patients, significant decreases after the confinement due to 
COVID-19 were found for the factors F1 (impact on eating symptoms), F2 (changes in eating 
style) and F4 (changes in emotion regulation). Obese patients also reported a significant decrease 
in weight, BMI and changes in the eating style. However, no significant changes emerged for the 
BN and OSFED patients.	
--- Insert Table 2 ---	
Figure 1 displays the means of the pre-post changes in the main variables of the study: weight, 
BMI, and CIES factors F1 to F4 (Table 3 contains the ANOVA comparing the changes between 
the groups). The obese patients were characterized by the highest change in weight (with a 
significant decrease of  3.2 kg, compared to an increase of nearly 1 kg for AN and BN patients and 
0 kg for OSFED patients). Patients with AN also improved on other CIES factors. Athough for 
the OSFED  patients there were no pre-post changes in weight and BMI, all other CIES 
factors deteriorated. 	
--- Insert Figure 1 ---	
 --- Insert Table 3 ---	
Evaluation of  telemedicine	
Table 4 contains information about the evaluation of alternatives to face to face therapy. 
Patients with AN, found these alternatives the least acceptable whereas people with obesity and 





This study was prompted by the need to assess the effects of confinement due to the COVID-19 
pandemic in vulnerable patients with ED and obesity(Fernández-Aranda et al., 2020; Todisco & 
Donini, 2020; Cornejo-Pareja et al., 2020). The three main aims were 
to first establish the psychometric properties of the specifically developed assessment measure 
(CIES), second to measure  the changes in eating and general symptomatology, and thirdly 
to establish the acceptability	of remote interventions.  	
The CFA confirmed the rational-theoretical structure of CIES into five-factors (impact on eating 
symptoms, changes in eating style, changes in anxiety/depression symptoms, changes in emotion 
regulation and evaluation of telemedicine), obtaining adequate goodness-of-fit. Other attributes of 
validity of this tool should be analyzed in future research (such as the convergent, discriminant 
and predictive validity, assessing the relationship between the CIES scores with other external 
measures related with eating behaviors).	
The impact of confinement was mixed and varied by diagnosis. In contrast to 
other studies  (Rodgers et al., 2020), the disordered eating improved during the COVID-19 
pandemic. Patients with obesity had a significant decrease both in weight/BMI and in eating 
psychopathology. This may be due to the fact that candidates for bariatric surgery were receiving 
ongoing nutritional management, and were selected based on minimal  psychopathology. Also 
the  findings from AN and BN patients do not align with previous studies which found a worsening 
in dietary restriction (Temorshuizen et al., 2020) and heightened psychological distress (Clark 
Bryan et al., 2020; Pierce et al., 2020). In the present study, AN and BN participants, did not 
present significant changes in weight/BMI. In this study people with AN, reported a significant 
decrease in ED symptomatology and in emotion dysregulation after confinement. Factors such as 
younger age and how participants were dealing with external control environments, might 
associated (Darrow et al., 2017; Treasure, et al. 2003). Interestingly, OSFED patients reported 
most adverse effects on eating behaviors and anxiety-depressive symptoms after confinement. As 
reported previously in the literature (Riesco et al., 2019), clinicians may need to pay special 
attention to subthreshold cases, who may be more sensitive to adverse environments (Vanzhula et 
al., 2019; Claes et al., 2019; Strand et al., 2019)	
Finally, although most patients reported being satisfasfied with the remote treatment used during 
the pandemic, in concordance with previous studies(Linardon et al., 2020), patients with AN were 
the least comfortable with the change. Other studies have reported on the distress caused by 
premature discharge from inpatient care with a lack of preparation (Clark Bryan et al., 2020). This 
sensitivity tochange  may be related with specific temperamental traits, such as 
managing uncertainty and may be specific therapy targets in future interventions (Datta et al., 
2020; Kannarkat et al., 2020; Baenas et al.,, 2020; Brown et al., 2017).	
 	
Limitations 	
Despite the novelty of this study, several limitations should be considered in the present study: 
memory bias due to the retrospective nature of the assessment, limited sample size and 
heterogeneity of the patient groups analyzed. 	
 	
CONCLUSIONS	
The present study provides empirical evidence on the psychometric robustness of the 
CIES tool. The effects of confinement, varied by ED subtype. Patients with AN and those 
with obesity endorsed a positive response whereas OSFED patients showed the 
highest deterioration  in eating symptomatology and in psychopathology. Furthermore, 
AN patients expressed the greatest dissatisfaction with adjustment to remote therapy	
The administration of the CIES in populations with ED and obesity may inform clinicians about 
how to prepare for adjustments to future environmentalchallenges. Further studies may need to be 
conducted in different countries with larger samples in order to be able to generalize these results.	
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Table 1 Internal consistency, fitting indexes in the CFA and correlation-matrix for CIES scores	
 	  	 Cronbach-alpha	 Fitting indices	
 	  	 Pre	 Post	 RMSEA	 CFI	 TLI	 SRMR	
F1.	 Impact on ED symptoms	 .805	 .806	 .061	 .937	 .917	 .088	
F2.	Changes - eating	 .922	 .910	 .072	 .941	 .924	 .080	
F3.	Changes- anxiety/depression	 .865	 .857	 .093	 .961	 .950	 .089	
F4.	Changes- emotion regulation	 .826	 .836	 .012	 .999	 .998	 .042	
F5.	Evaluation telemedicine	 .939	 .033	 .983	 .964	 .036	
 	Correlation-matrix	 F2pre	 F3pre	 F4pre	 F1post	 F2post	 F3post	 F4post	 F5	
F1.	Pre - Impact on ED symptoms	 .675†	 .368†	 .401†	 .547†	 .480†	 .278†	 .256†	 .006	
F2.	Pre - Changes- eating	 --- 	 .489†	 .498†	 .451†	 .657†	 .341†	 .338†	 .160	
F3.	Pre - Changes- anxiety/depression	  	 --- 	 .736†	 .144	 .345†	 .729†	 .549†	 -.032	
F4.	Pre - Changes- emotional regulation	  	  	 --- 	 .154	 .281†	 .553†	 .765†	 -.145	
F1.	Post - Impact on ED symptoms	  	  	  	 --- 	 .656†	 .365†	 .331†	 -.120	
F2.	Post - Changes - eating	  	  	  	  	 --- 	 .528†	 .444†	 -.008	
F3.	Post - Changes - anxiety/depression	  	  	  	  	  	 --- 	 .746†	 -.208	
F4.	Post - Changes - emotion regulation	  	  	  	  	  	  	 --- 	 -.183	
F5.	Evaluation telemedicine	  	  	  	  	  	  	  	  	
Note. RMSEA: Root Mean Squared Error of Approximation. 	
CFI: Comparative Fit Index. TLI: Tucker-Lewis Index. 	
SRMR: Standardized Root Mean Squared Residual. 	
†Bold: correlation coefficient with an effect size in the moderate (|R|>0.24) to high (|R|>0.37) range.	
	
	
Table 2 Changes during confinement stratified by diagnostic subtype	
 	 Pre	 Post	  	  	
Anorexia (n=55)	 Mean	 SD	 Mean	 SD	 p	 |d|	
Weight (kg)	 49.16	 6.91	 50.27	 6.52	 .056	 0.17	
BMI (kg/m2)	 18.25	 2.25	 18.67	 2.14	 .058	 0.19	
CIES-F1 Impact ED symptoms	 11.87	 6.79	 9.40	 5.61	 .015*	 0.40	
CIES-F2 Changes - eating	 8.76	 9.61	 6.11	 6.94	 .023*	 0.32	
CIES-F3 Changes-  anxiety-depression	 18.29	 9.69	 17.80	 9.64	 .662	 0.05	
CIES-F4 Changes - emotion regulation	 9.47	 4.63	 8.33	 4.86	 .046*	 0.24	
 	 n	 %	 n	 %	 P	 |d|	
Tobacco	 15	 27.3%	 15	 27.3%	 1.00	 0.00	
Alcohol	 6	 10.9%	 5	 9.1%	 1.00	 0.06	
Other illegal drugs	 4	 7.3%	 3	 5.5%	 1.00	 0.07	
Addictive Behaviours	 25	 45.5%	 31	 56.4%	 .180	 0.22	
Bulimia (n=18)	 Mean	 SD	 Mean	 SD	 p	 |d|	
Weight (kg)	 65.26	 10.93	 66.22	 11.81	 .230	 0.08	
BMI (kg/m2)	 24.13	 3.75	 24.47	 4.02	 .243	 0.09	
CIES-F1 Impact ED symptoms	 15.72	 6.31	 14.94	 6.04	 .617	 0.13	
CIES-F2 Changes - eating	 19.50	 9.75	 17.72	 7.51	 .306	 0.20	
CIES-F3 Changes-  anxiety-depression	 18.61	 8.89	 20.22	 7.12	 .125	 0.20	
CIES-F4 Changes - emotion regulation	 9.33	 4.19	 9.56	 4.26	 .521	 0.05	
 	 n	 %	 n	 %	 p	 |d|	
Tobacco	 5	 27.8%	 5	 27.8%	 1.00	 0.00	
Alcohol	 6	 33.3%	 6	 33.3%	 1.00	 0.00	
Other illegal drugs	 1	 5.6%	 1	 5.6%	 1.00	 0.00	
Addictive Behaviours	 12	 66.7%	 13	 72.2%	 1.00	 0.12	
OSFED (n=14)	 Mean	 SD	 Mean	 SD	 p	 |d|	
Weight (kg)	 63.07	 8.99	 62.91	 8.48	 .926	 0.02	
BMI (kg/m2)	 23.40	 3.38	 23.30	 2.84	 .886	 0.03	
CIES-F1 Impact ED symptoms	 12.29	 6.60	 13.14	 8.37	 .602	 0.11	
CIES-F2 Changes - eating	 11.57	 10.80	 13.36	 12.68	 .140	 0.15	
CIES-F3 Changes-  anxiety-depression	 14.07	 10.23	 18.21	 10.54	 .071	 0.40	
CIES-F4 Changes - emotion regulation	 5.14	 4.28	 6.36	 4.80	 .066	 0.27	
 	 n	 %	 n	 %	 p	 |d|	
Tobacco	 6	 42.9%	 6	 42.9%	 1.00	 0.00	
Alcohol	 3	 21.4%	 4	 28.6%	 1.00	 0.17	
Other illegal drugs	 0	 0.0%	 0	 0.0%	 1.00	 0.00	
Addictive Behaviours	 7	 50.0%	 9	 64.3%	 .500	 0.29	
OBESE (n=34)	 Mean	 SD	 Mean	 SD	 p	 |d|	
Weight (kg)	 109.62	 20.51	 106.46	 19.61	 .035*	 0.16	
BMI (kg/m2)	 41.15	 7.37	 39.94	 6.86	 .037*	 0.17	
CIES-F1 Impact ED symptoms	 13.29	 6.06	 13.56	 6.21	 .645	 0.04	
CIES-F2 Changes - eating	 14.00	 10.40	 9.82	 9.40	 .017*	 0.42	
CIES-F3 Changes-  anxiety-depression	 14.29	 9.80	 14.00	 10.33	 .765	 0.03	
CIES-F4 Changes - emotion regulation	 4.65	 4.69	 4.06	 4.36	 .280	 0.13	
 	 n	 %	 n	 %	 p	 |d|	
Tobacco	 5	 14.7%	 4	 11.8%	 1.00	 0.09	
Alcohol	 6	 17.6%	 4	 11.8%	 .500	 0.17	
Other illegal drugs	 1	 2.9%	 0	 0.0%	 1.00	 0.34	
Addictive Behaviours	 23	 67.6%	 23	 67.6%	 1.00	 0.00	
Note. OSFED: other specificied feeding eeating disorders. SD: standard deviation. *Bold: significant comparison. 	
	
	
Table 3 Comparison of the differences (post-pre changes) for the weight and the CIES factor 
scores	
 	
Anorexia (AN)	 Bulimia (BN)	 OSFED	 Obesity 
(OBES)	
Significant	
 	 N=55	 N=18	 N=14	 N=34	 Pairwise	
 	 Mean	 SD	 Mean	 SD	 Mean	 SD	 Mean	 SD	 Comparisons	
Weight (kg)	 1.11	 4.23	 0.96	 3.27	 -0.16	 6.48	 -3.16	 8.38	 OBES ¹  (AN=BN=OSFED)	
BMI (kg/m2)	 0.43	 1.63	 0.35	 1.22	 -0.10	 2.51	 -1.21	 3.24	 OBES ¹  (AN=BN=OSFED)	
CIES-F1 Impact ED 
symptoms	
-2.47	 7.31	 -0.78	 6.48	 0.86	 6.00	 0.26	 3.31	 AN ¹  (BN=OSFED=OBES)	
CIES-F2 Changes - eating	 -2.65	 8.38	 -1.78	 7.14	 1.79	 4.25	 -4.18	 9.70	 OSFED ¹  (AN=BN)  ¹  OBES	
CIES-F3 Changes-  anx-
dep.	
-0.49	 8.29	 1.61	 4.23	 4.14	 7.89	 -0.29	 5.70	 OSFED ¹  (AN=BN=OBES)	
CIES-
F4 Changes - emotion	
-1.15	 4.15	 0.22	 1.44	 1.21	 2.26	 -0.59	 3.12	 OSFED ¹  (AN=BN=OBES)	

























Table 4 Comparison of the CIES F5 evaluation of telemedicine between the groups	
Anorexia (AN)	 Bulimia (BN)	 OSFED	 Obesity	
n=55	 n=18	 n=14	 n=34	
Mean	 SD	 Mean	 SD	 Mean	 SD	 Mean	 SD	
25.58	 10.40	 28.61	 6.46	 29.50	 9.53	 28.97	 7.25	
Pairwise comparisons	 p	 |d|	  	  	  	  	
Anorexia vs Bulimia	 .218	 0.35	  	  	  	  	
Anorexia vs OSFED	 .148	 0.39	  	  	  	  	
Anorexia vs Obesity	 .047*	 0.38	  	  	  	  	
Bulimia vs OSFED	 .782	 0.11	  	  	  	  	
Bulimia vs Obesity	 .891	 0.05	  	  	  	  	
OSFED vs Obesity	 .853	 0.06	  	  	  	  	










Figure 1 Differences (post-pre changes) in weight, BMI and CIES factors among the groups.	
	
 
